PATTERNS OF DUVELISIB-INDUCED LYMPHOCYTOSIS IN PATIENTS WITH R/R CLL OR SLL INCLUDING THOSE WITH HIGH-RISK FACTORS TREATED IN THE DUO TRIAL

Authors :: Jennifer R. Brown
Ian W. Flinn
Matthew S. Davids
David T. Weaver
S. Hidy
Nicholas Chiorazzi
Shih-Shih Chen
Stephanie Lustgarten
J. Pachter
Jaqueline C. Barrientos
Amanda F. Cashen
Source :: Hematological Oncology. 37:216-217
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Lymphocytosis
business.industry
Hematology
General Medicine
High risk factors
Duvelisib
chemistry.chemical_compound
chemistry
Internal medicine
medicine
In patient
medicine.symptom
business

Tools